-
Methylprednisolone Sodium Succinate in Translation
2026-08-18
A mechanistic and strategic guide to using Methylprednisolone Sodium Succinate for inflammation, immunology, tumor-cell apoptosis, and acute spinal cord injury treatment research.
-
Puromycin aminonucleoside Podocyte Injury Workflow
2026-08-17
Build a controlled podocyte injury model that connects cellular morphology with proteinuria, glomerular pathology, and molecular readouts. This workflow uses Puromycin aminonucleoside as a nephrotoxic agent for nephrotic syndrome research while emphasizing dose-finding, pH-aware uptake studies, and assay-specific troubleshooting.
-
3X FLAG Peptide: A Structure-Aware Assay Guide
2026-08-17
The 3X (DYKDDDDK) Peptide combines dense epitope presentation with a compact, hydrophilic design for recombinant protein detection and purification. This guide connects its biochemical behavior to cryo-EM sample decisions, metal-sensitive assays, and protein crystallization workflows.
-
Omeprazole A2845: Practical Assay Workflow
2026-08-15
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research and related antiulcer activity studies. It is intended for scientific research workflows only; its limited aqueous solubility, storage requirements, and dossier-based potency values require matched vehicle controls and assay-specific validation.
-
Acridine Orange hydrochloride Workflow Guide
2026-08-14
Acridine Orange hydrochloride provides a practical two-channel approach for distinguishing nucleic-acid-associated green and red fluorescence in cell and flow cytometric workflows. It is appropriate for exploratory cell cycle analysis, apoptosis detection, and DNA/RNA differential staining, but exact staining concentrations, incubation times, and biological interpretation require laboratory optimization because no directly matched paper protocol is available here.
-
Omeprazole A2845: H+,K+-ATPase Workflow Guide
2026-08-14
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for gastric acid secretion research, functional acid-formation assays, and selected antiulcer activity studies. Its water and ethanol insolubility make solvent preparation and solution stability important; it is for scientific research only and not for diagnostic, clinical, or medical use.
-
Moxifloxacin: From Gyrase Assay to Cell Models
2026-08-13
Moxifloxacin research is strongest when bacterial target engagement, mammalian-cell responses, and organism-level biomarkers are interpreted as separate evidence layers. This guide connects DNA gyrase pharmacology with assay design, retinal ganglion-cell studies, and antibiotic-associated metabolic responses.
-
Prenatal PS Nanoplastics Activate MAPK/ERK/UHRF1
2026-08-13
A 2026 study links prenatal and lactational exposure to polystyrene nanoplastics with vascular lipid accumulation in male mouse offspring and identifies a MAPK/ERK/UHRF1 signaling axis. Pharmacological pathway inhibition and UHRF1 knockdown provide complementary evidence that this axis contributes to lipid dysregulation in vascular smooth muscle cells.
-
Omeprazole (A2845): Research Workflow Guide
2026-08-12
This guide explains how to use Omeprazole (SKU A2845) in controlled H+,K+-ATPase inhibition and gastric acid secretion research when no directly matched paper evidence is available. It covers identity, solubility, storage, assay setup, and QC while defining why the compound should not be used for diagnostic, therapeutic, or medical purposes.
-
Hyaluronic Acid Sodium Salt in Translational Nanomedicine
2026-08-12
Hyaluronic acid sodium salt is more than an extracellular matrix reagent: it can serve as a controllable biological interface for tissue modeling and nucleic acid delivery. This article examines how recent work on HA-coated siRNA nanoparticles for Pseudomonas aeruginosa lung injury informs experimental design, translational strategy, and product selection.
-
HNRNPU Lactylation Rewires Serine Metabolism
2026-08-11
This Advanced Science study identifies HNRNPU lysine 181 lactylation as a non-histone mechanism linking lactate accumulation to PHGDH-dependent serine biosynthesis in cervical cancer. The work connects a post-translational modification switch with RNA stability, redox balance, nucleotide production, tumor growth, and a pharmacological response to Pazopanib.
-
Omeprazole (A2845): H+,K+-ATPase Workflow
2026-08-11
Omeprazole (SKU A2845) provides a defined research tool for testing H+,K+-ATPase inhibition and histamine-stimulated gastric acid secretion. It is intended for controlled laboratory studies, including antiulcer mechanism work, and should not be used for diagnostic, clinical, or medical applications.
-
Lactate–HMGB1 Signaling in Polymicrobial Sepsis
2026-08-10
The reference study identifies lactate as an active regulator of macrophage HMGB1 release rather than only a prognostic marker of sepsis. It links lactate uptake and GPR81 signaling to HMGB1 lactylation, acetylation, exosomal export, endothelial hyperpermeability, and septic mortality, providing a mechanistic framework for targeting lactate-associated inflammation.
-
WIP1, p38 MAPK, and Pyroptosis in Septic AKI
2026-08-09
Wang and colleagues identify WIP1/PPM1D as a protective regulator of renal tubular pyroptosis in sepsis-associated acute kidney injury, acting largely through suppression of p38 MAPK phosphorylation. By combining single-cell sequencing, LPS injury models, human acute tubular injury samples, and pharmacological inhibition, the study connects WIP1 expression with a potentially actionable inflammatory cell-death pathway.
-
FerroOrange for Live-Cell Fe²⁺ and Ferroptosis
2026-08-08
FerroOrange is a Fe²⁺ fluorescent probe for resolving intracellular iron changes in living cells. This article explains how to use its signal to strengthen ferroptosis and ischemic-neuron assay design without confusing ferrous-ion detection with proof of cell death.